Vaqta
Vaqta
Vaqta (/vækˈtɑː/) is a vaccine used to prevent hepatitis A, a contagious liver disease caused by the hepatitis A virus (HAV). It is produced by Merck & Co., an American multinational pharmaceutical company.
Etymology
The term "Vaqta" is a trade name and does not have a known etymology. It is a common practice in pharmaceutical naming to create unique, memorable names for new medications.
Usage
Vaqta is used to immunize individuals against hepatitis A. It is typically administered in two doses, with the second dose given six to eighteen months after the first. The vaccine is recommended for all children over the age of one, travelers to certain countries, and others at high risk of infection.
Related Terms
- Hepatitis A virus (HAV): The virus that causes hepatitis A.
- Vaccine: A biological preparation that provides active acquired immunity to a particular infectious disease.
- Immunization: The process by which an individual's immune system becomes fortified against an agent.
- Merck & Co.: The pharmaceutical company that produces Vaqta.
See Also
External links
- Medical encyclopedia article on Vaqta
- Wikipedia's article - Vaqta
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski